MK0859
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ambulatory Blood Pressure
Conditions
Ambulatory Blood Pressure
Trial Timeline
Jul 1, 2006 → Sep 1, 2006
NCT ID
NCT00565006About MK0859
MK0859 is a phase 1 stage product being developed by Merck for Ambulatory Blood Pressure. The current trial status is completed. This product is registered under clinical trial identifier NCT00565006. Target conditions include Ambulatory Blood Pressure.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00565006 | Phase 1 | Completed |
| NCT00565292 | Phase 1 | Completed |
| NCT00325455 | Phase 2 | Terminated |
Competing Products
1 competing product in Ambulatory Blood Pressure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| ertapenem | Merck | Approved | 85 |